Nan Fung Trinity’s Akero Therapeutics AKRO Stock Holding History

Nan Fung Trinity’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-110,650	Closed	-$5.25M	–	79
2025 Q3	$5.25M	Hold	110,650	–	–	0.52%	52
2025 Q2	$5.9M	Buy	+110,650	New	+$5.03M	0.71%	44

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nan Fung Trinity's AKRO Position: Q4 2025 in Review

Nan Fung Trinity sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 110,650 shares — an estimated $5.25M sold.

Nan Fung Trinity first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $5.9M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Nan Fung Trinity reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Nan Fung Trinity sold 110,650 Akero Therapeutics shares in Q4 2025, an estimated $5.25M.
Nan Fung Trinity first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
Nan Fung Trinity's Akero Therapeutics position peaked at $5.9M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Nan Fung Trinity's 13F filing for Q4 2025, filed 4 Feb 2026.